tiprankstipranks
Trending News
More News >
Thermo Fisher Scientific (TMO)
:TMO
US Market
Advertisement

Thermo Fisher (TMO) Stock Forecast & Price Target

Compare
4,871 Followers
See the Price Targets and Ratings of:

TMO Analyst Ratings

Strong Buy
18Ratings
Strong Buy
14 Buy
4 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Thermo
Fisher
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TMO Stock 12 Month Forecast

Average Price Target

$543.89
▲(16.61% Upside)
Based on 18 Wall Street analysts offering 12 month price targets for Thermo Fisher in the last 3 months. The average price target is $543.89 with a high forecast of $590.00 and a low forecast of $490.00. The average price target represents a 16.61% change from the last price of $466.42.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"395":"$395","620":"$620","451.25":"$451.3","507.5":"$507.5","563.75":"$563.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":590,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$590.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":543.89,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$543.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":490,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$490.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[395,451.25,507.5,563.75,620],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,463.04,472.80615384615385,482.57230769230773,492.33846153846156,502.1046153846154,511.87076923076927,521.636923076923,531.4030769230769,541.1692307692308,550.9353846153846,560.7015384615385,570.4676923076923,580.2338461538461,{"y":590,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,463.04,469.2592307692308,475.47846153846154,481.6976923076923,487.91692307692307,494.13615384615383,500.35538461538465,506.5746153846154,512.7938461538462,519.0130769230769,525.2323076923077,531.4515384615385,537.6707692307692,{"y":543.89,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,463.04,465.11384615384617,467.1876923076923,469.26153846153846,471.3353846153846,473.40923076923076,475.4830769230769,477.5569230769231,479.63076923076926,481.7046153846154,483.77846153846156,485.8523076923077,487.92615384615385,{"y":490,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":619.75,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":613.07,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":611.33,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":556.46,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":528.56,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":519.25,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":596.63,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":527.96,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":482.47,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":419.46,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":396.06,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":421.47,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":463.04,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$590.00Average Price Target$543.89Lowest Price Target$490.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on TMO
TipRanks AITipRanks
Not Ranked
TipRanks
$539
Buy
15.56%
Upside
Reiterated
07/25/25
Thermo Fisher's strong financial performance, highlighted by robust margins and operational efficiency, drives the positive outlook. The bullish technical indicators and optimistic earnings call further support the score. However, valuation concerns due to a high P/E ratio and challenges in specific market segments temper the overall assessment.
Wells Fargo
$565
Buy
21.14%
Upside
Reiterated
08/04/25
Thermo Fisher's Strong Market Position and Growth Drive Buy Rating
CMB International Securities Analyst forecast on TMO
Jill WuCMB International Securities
CMB International Securities
$553
Buy
18.56%
Upside
Reiterated
07/28/25
Thermo Fisher's Strong Performance and Strategic Initiatives Justify Buy Rating Amid Industry Recovery
Scotiabank Analyst forecast on TMO
Sung Ji NamScotiabank
Scotiabank
$590
Buy
26.50%
Upside
Reiterated
07/28/25
Thermo Fisher (TMO) Gets a Buy from Scotiabank
UBS
$460$500
Hold
7.20%
Upside
Reiterated
07/24/25
Thermo Fisher price target raised to $500 from $460 at UBSThermo Fisher price target raised to $500 from $460 at UBS
Robert W. Baird
$553$567
Buy
21.56%
Upside
Reiterated
07/24/25
Thermo Fisher price target raised to $567 from $553 at BairdThermo Fisher price target raised to $567 from $553 at Baird
Jefferies
$560
Buy
20.06%
Upside
Reiterated
07/24/25
Analysts Are Bullish on These Healthcare Stocks: Thermo Fisher (TMO), Viking Therapeutics (VKTX)
Citi
$475$500
Hold
7.20%
Upside
Reiterated
07/24/25
Analysts Offer Insights on Healthcare Companies: Icon (NASDAQ: ICLR), Merck & Company (NYSE: MRK) and Thermo Fisher (NYSE: TMO)
HSBC
$510
Hold
9.34%
Upside
Downgraded
07/24/25
Thermo Fisher downgraded to Hold from Buy at HSBCThermo Fisher downgraded to Hold from Buy at HSBC
Morgan Stanley Analyst forecast on TMO
Patrick WoodMorgan Stanley
Morgan Stanley
$550$560
Buy
20.06%
Upside
Reiterated
07/24/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
Bernstein Analyst forecast on TMO
Eve BursteinBernstein
Bernstein
$560$570
Buy
22.21%
Upside
Reiterated
07/24/25
Bernstein Remains a Buy on Thermo Fisher (TMO)Bernstein SocGen Group analyst Eve Burstein raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $570.00 (from $560.00) while maintaining an Outperform rating.
Stifel Nicolaus Analyst forecast on TMO
Daniel AriasStifel Nicolaus
Stifel Nicolaus
$583
Buy
24.99%
Upside
Reiterated
07/24/25
Thermo Fisher (TMO) Receives a Buy from Stifel Nicolaus
Raymond James Analyst forecast on TMO
Andrew CooperRaymond James
Raymond James
$535
Buy
14.70%
Upside
Reiterated
07/24/25
Thermo Fisher (TMO) Receives a Buy from Raymond James
Leerink Partners Analyst forecast on TMO
Puneet SoudaLeerink Partners
Leerink Partners
$500
Buy
7.20%
Upside
Reiterated
07/24/25
Positive Outlook and Strategic Growth Plans Bolster Thermo Fisher's Stock RatingWe continue to be structurally positive on TMO and reiterate our $500 PT and OP rating.
Barclays Analyst forecast on TMO
Luke SergottBarclays
Barclays
$450$490
Hold
5.06%
Upside
Reiterated
07/24/25
Barclays Keeps Their Hold Rating on Thermo Fisher (TMO)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on TMO
TipRanks AITipRanks
Not Ranked
TipRanks
$539
Buy
15.56%
Upside
Reiterated
07/25/25
Thermo Fisher's strong financial performance, highlighted by robust margins and operational efficiency, drives the positive outlook. The bullish technical indicators and optimistic earnings call further support the score. However, valuation concerns due to a high P/E ratio and challenges in specific market segments temper the overall assessment.
Wells Fargo
$565
Buy
21.14%
Upside
Reiterated
08/04/25
Thermo Fisher's Strong Market Position and Growth Drive Buy Rating
CMB International Securities Analyst forecast on TMO
Jill WuCMB International Securities
CMB International Securities
$553
Buy
18.56%
Upside
Reiterated
07/28/25
Thermo Fisher's Strong Performance and Strategic Initiatives Justify Buy Rating Amid Industry Recovery
Scotiabank Analyst forecast on TMO
Sung Ji NamScotiabank
Scotiabank
$590
Buy
26.50%
Upside
Reiterated
07/28/25
Thermo Fisher (TMO) Gets a Buy from Scotiabank
UBS
$460$500
Hold
7.20%
Upside
Reiterated
07/24/25
Thermo Fisher price target raised to $500 from $460 at UBSThermo Fisher price target raised to $500 from $460 at UBS
Robert W. Baird
$553$567
Buy
21.56%
Upside
Reiterated
07/24/25
Thermo Fisher price target raised to $567 from $553 at BairdThermo Fisher price target raised to $567 from $553 at Baird
Jefferies
$560
Buy
20.06%
Upside
Reiterated
07/24/25
Analysts Are Bullish on These Healthcare Stocks: Thermo Fisher (TMO), Viking Therapeutics (VKTX)
Citi
$475$500
Hold
7.20%
Upside
Reiterated
07/24/25
Analysts Offer Insights on Healthcare Companies: Icon (NASDAQ: ICLR), Merck & Company (NYSE: MRK) and Thermo Fisher (NYSE: TMO)
HSBC
$510
Hold
9.34%
Upside
Downgraded
07/24/25
Thermo Fisher downgraded to Hold from Buy at HSBCThermo Fisher downgraded to Hold from Buy at HSBC
Morgan Stanley Analyst forecast on TMO
Patrick WoodMorgan Stanley
Morgan Stanley
$550$560
Buy
20.06%
Upside
Reiterated
07/24/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
Bernstein Analyst forecast on TMO
Eve BursteinBernstein
Bernstein
$560$570
Buy
22.21%
Upside
Reiterated
07/24/25
Bernstein Remains a Buy on Thermo Fisher (TMO)Bernstein SocGen Group analyst Eve Burstein raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $570.00 (from $560.00) while maintaining an Outperform rating.
Stifel Nicolaus Analyst forecast on TMO
Daniel AriasStifel Nicolaus
Stifel Nicolaus
$583
Buy
24.99%
Upside
Reiterated
07/24/25
Thermo Fisher (TMO) Receives a Buy from Stifel Nicolaus
Raymond James Analyst forecast on TMO
Andrew CooperRaymond James
Raymond James
$535
Buy
14.70%
Upside
Reiterated
07/24/25
Thermo Fisher (TMO) Receives a Buy from Raymond James
Leerink Partners Analyst forecast on TMO
Puneet SoudaLeerink Partners
Leerink Partners
$500
Buy
7.20%
Upside
Reiterated
07/24/25
Positive Outlook and Strategic Growth Plans Bolster Thermo Fisher's Stock RatingWe continue to be structurally positive on TMO and reiterate our $500 PT and OP rating.
Barclays Analyst forecast on TMO
Luke SergottBarclays
Barclays
$450$490
Hold
5.06%
Upside
Reiterated
07/24/25
Barclays Keeps Their Hold Rating on Thermo Fisher (TMO)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Thermo Fisher

1 Month
xxx
Success Rate
12/19 ratings generated profit
63%
Average Return
+1.14%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 63.16% of your transactions generating a profit, with an average return of +1.14% per trade.
3 Months
xxx
Success Rate
30/43 ratings generated profit
70%
Average Return
+3.94%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.77% of your transactions generating a profit, with an average return of +3.94% per trade.
1 Year
Sung Ji NamScotiabank
Success Rate
16/19 ratings generated profit
84%
Average Return
+15.42%
reiterated a buy rating 11 days ago
Copying Sung Ji Nam's trades and holding each position for 1 Year would result in 84.21% of your transactions generating a profit, with an average return of +15.42% per trade.
2 Years
xxx
Success Rate
16/19 ratings generated profit
84%
Average Return
+31.63%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 84.21% of your transactions generating a profit, with an average return of +31.63% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TMO Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
2
2
2
0
0
Buy
36
28
38
41
41
Hold
7
5
6
7
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
45
35
46
48
48
In the current month, TMO has received 41 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. TMO average Analyst price target in the past 3 months is 543.89.
Each month's total comprises the sum of three months' worth of ratings.

TMO Financial Forecast

TMO Earnings Forecast

Next quarter’s earnings estimate for TMO is $5.50 with a range of $5.47 to $5.62. The previous quarter’s EPS was $5.36. TMO beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year TMO has Preformed in-line its overall industry.
Next quarter’s earnings estimate for TMO is $5.50 with a range of $5.47 to $5.62. The previous quarter’s EPS was $5.36. TMO beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year TMO has Preformed in-line its overall industry.

TMO Sales Forecast

Next quarter’s sales forecast for TMO is $10.90B with a range of $10.85B to $11.00B. The previous quarter’s sales results were $10.86B. TMO beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.64% of the time in the same period. In the last calendar year TMO has Preformed in-line its overall industry.
Next quarter’s sales forecast for TMO is $10.90B with a range of $10.85B to $11.00B. The previous quarter’s sales results were $10.86B. TMO beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.64% of the time in the same period. In the last calendar year TMO has Preformed in-line its overall industry.

TMO Stock Forecast FAQ

What is TMO’s average 12-month price target, according to analysts?
Based on analyst ratings, Thermo Fisher Scientific’s 12-month average price target is 543.89.
    What is TMO’s upside potential, based on the analysts’ average price target?
    Thermo Fisher Scientific has 16.61% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TMO a Buy, Sell or Hold?
          Thermo Fisher Scientific has a consensus rating of Strong Buy which is based on 14 buy ratings, 4 hold ratings and 0 sell ratings.
            What is Thermo Fisher Scientific’s price target?
            The average price target for Thermo Fisher Scientific is 543.89. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $590.00 ,the lowest forecast is $490.00. The average price target represents 16.61% Increase from the current price of $466.42.
              What do analysts say about Thermo Fisher Scientific?
              Thermo Fisher Scientific’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
                How can I buy shares of TMO?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis